前扣带皮层μ与κ阿片受体对下行痛觉控制的对立效应
该研究在大鼠脊髓神经结扎慢性痛模型中评估前扣带皮层μ与κ阿片受体对下行痛觉控制(条件痛觉调制临床前对应物)的影响。结果发现慢性痛大鼠同侧后爪下行痛觉控制减弱,前扣带皮层注射吗啡或κ受体拮抗剂均可恢复该控制而不改变痛觉过敏,而κ受体激动剂在正常大鼠中抑制下行控制。提示前扣带皮层κ受体激活削弱下行痛觉控制,μ受体激活或κ受体拮抗可恢复之。
要点
- 慢性痛大鼠同侧后爪下行痛觉控制减弱,对侧不受影响。
- 前扣带皮层注射吗啡或κ受体拮抗剂可恢复慢性痛大鼠的下行痛觉控制。
- κ受体激动剂在正常大鼠中抑制下行痛觉控制,提示κ受体激活削弱该控制。
核心结论
- 前扣带皮层κ阿片受体激活削弱下行痛觉控制,在正常动物和慢性痛适应反应中均如此,可能通过增强净下行易化实现。
- 前扣带皮层μ阿片受体激活或κ阿片受体拮抗均可恢复下行痛觉控制,提供非成瘾性替代阿片类镇痛药的思路。
- Navacaprant已进入高级临床试验。
研究设计与样本
- 雄性Sprague-Dawley大鼠,脊髓神经结扎诱导慢性痛模型或假手术对照。
- 评估前扣带皮层μ阿片受体激活对下行痛觉控制的影响。
- 探索正常大鼠或神经病理痛动物前扣带皮层κ阿片受体激活或抑制的后果。
- 下行痛觉控制以后爪对有害压力的缩足反应(测试刺激)在前爪注射辣椒素(条件刺激)缺席或存在时测量。
主要发现
- 脊髓神经结扎大鼠同侧后爪下行痛觉控制减弱,对侧未减弱。
- 前扣带皮层双侧注射吗啡对假手术大鼠无影响,但在神经病理痛大鼠中恢复减弱的下行痛觉控制而不改变痛觉过敏。
- 前扣带皮层双侧微注射κ阿片受体拮抗剂nor-binaltorphimine和navacaprant在神经病理痛大鼠中重建下行痛觉控制而不改变痛觉过敏,对假手术大鼠无影响。
- 正常大鼠前扣带皮层双侧注射κ阿片受体激动剂U69,593抑制下行痛觉控制而不改变缩足阈值。
临床怎么用
- 前扣带皮层κ阿片受体拮抗(如navacaprant)可能恢复慢性痛患者减弱的下行痛觉调制,且不依赖阿片类镇痛机制。
- 前扣带皮层μ阿片受体激活可恢复下行痛觉控制,但需注意阿片类药物的成瘾性风险。
局限性
- 研究为动物实验,结果需临床验证。
- 仅使用雄性大鼠,未评估性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The efficiency of descending pain modulation, commonly assessed with the conditioned pain modulation procedure, is diminished in patients with chronic pain. The authors hypothesized that the efficiency of pain modulation is controlled by cortical opioid circuits. METHODS: This study evaluated the effects of µ opioid receptor activation in the anterior cingulate cortex on descending control of nociception, a preclinical correlate of conditioned pain modulation, in male Sprague-Dawley rats with spinal nerve ligation-induced chronic pain or in sham-operated controls. Additionally, the study explored the consequences of respective activation or inhibition of κ opioid receptor in the anterior cingulate cortex of naive rats or animals with neuropathic pain. Descending control of nociception was measured as the hind paw withdrawal response to noxious pressure (test stimulus) in the absence or presence of capsaicin injection in the forepaw (conditioning stimulus). RESULTS: Descending control of nociception was diminished in the ipsilateral, but not contralateral, hind paw of rats with spinal nerve ligation. Bilateral administration of morphine in the anterior cingulate cortex had no effect in shams but restored diminished descending control of nociception without altering hypersensitivity in rats with neuropathic pain. Bilateral anterior cingulate cortex microinjection of κ opioid receptor antagonists, including nor-binaltorphimine and navacaprant, also re-established descending control of nociception in rats with neuropathic pain without altering hypersensitivity and with no effect in shams. Conversely, bilateral injection of a κ opioid receptor agonist, U69,593, in the anterior cingulate cortex of naive rats inhibited descending control of nociception without altering withdrawal thresholds. CONCLUSIONS: Anterior cingulate cortex κ opioid receptor activation therefore diminishes descending control of nociception both in naive animals and as an adaptive response to chronic pain, likely by enhancing net descending facilitation. Descending control of nociception can be restored by activation of μ opioid receptors in the anterior cingulate cortex, but also by κ opioid receptor antagonists, providing a nonaddictive alternative to opioid analgesics. Navacaprant is now in advanced clinical trials.
引用
- Navratilova E, Qu C, Ji G, et al. Opposing Effects on Descending Control of Nociception by µ and κ Opioid Receptors in the Anterior Cingulate Cortex. Anesthesiology. 2024. PMID: 37725756. doi:10.1097/ALN.0000000000004773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。